Arrr! Aye, the booty be worth 995861 doubloons, me hearties!
2023-08-25
Avast ye hearties! In the NOAH-AFNET 6 trial, tis discovered that using edoxaban to thin the blood of scallywags with atrial high-rate episodes didn't bring any advantage, but instead caused more bleedings. Arrr!
Arr matey! Listen up, ye scurvy dogs! I've got some news from the 17th century, straight from the swashbuckling world of pirates, or as they call themselves today - doctors. Aye, it seems they've been conducting trials with a fancy new medicine called edoxaban. Now, this medicine be used for patients with atrial high-rate episodes detected by implantable devices, whatever that means.But here's the rub, me hearties. This edoxaban doesn't seem to be doin' any good for the patients. Nay, it didn't show any benefit at all in a trial called NOAH-AFNET 6. Ah, the doctors and their fancy names for their experiments! I bet they had a parrot named NOAH-AFNET 6 too!
But there be more to this tale. Brace yourselves, lads and lasses, for the twist in the plot. This edoxaban, while not provin' its worth, did increase the risk of bleeding. Aye, ye heard that right! The patients who took this medicine were more likely to be bleedin' than those who didn't. It be like havin' a hole in yer ship and expectin' it to sail straight!
Now, I reckon ye be wonderin', why would the doctors be testin' this medicine in the first place if it be doin' more harm than good? I be havin' no clue, me mateys. But ya know what they say - "The sea be a mysterious place, and so be the world of medicine!"
So there ye have it, ye landlubbers! Edoxaban may be a fancy word, but it be no help for those with atrial high-rate episodes. If any o' ye be thinkin' of takin' it, be warned - ye might end up bleedin' like a stuck pig! Stay safe, me hearties, and keep yer wits about ye!